2024 was an exceptional year for ODAIA, marked by significant product launches, strategic partnerships, and industry recognition. Our AI-driven solutions have continued to empower pharmaceutical sales teams, driving meaningful HCP engagement and delivering measurable value. Here's a comprehensive look at our key achievements and innovations. 

Major Product Advancements & Updates 

This year, ODAIA focused on ease of adoption, rapid time-to-value, and facilitating seamless implementation to guarantee AI success. We understand that organizations need solutions that not only address immediate challenges but also align with their broader goals and timelines. 

This past year, ODAIA was announced as an official Veeva Product & GenAI partner. ODAIA’s seamless integration with Veeva and Vault CRM provides real-time, AI-driven insights within a sales rep’s workflow. 

• Access new targeting in hours instead of weeks, and easily identify impactful HCPs within a territory 
• GenAI provides the most relevant insights summarized for each HCP 
• Reduce call-planning time with individualized, territory specific call plans that consider recent events & predictive behaviors 
• Optimize reps’ schedules with call plans and map view, so reps consistently make the best trade-offs

ODAIA introduced an intuitive Map View feature to enable  intelligent route planning. By visualizing HCPs by their PowerScore or segment, reps can efficiently plan their week around anchor appointments or fill time between calls. Map View & Route planning is available both within Veeva, and the native ODAIA app. 

This year, we introduced a more flexible approach to adopting ODAIA's platform, making it easier for organizations to start with the features and functions that best fit their immediate needs and budgets. By offering modular solutions, teams can begin addressing their most pressing challenges today while having the flexibility to expand as they realize value and align with stakeholders’ timelines and goals.

ODAIA’s Solutions:

1. Engagement Intelligence: Delivering instant AI impact with personalized insights, call lists, and route planning directly in your CRM. This module allows you to bring in your existing targeting & segmentation while maximizing HCP engagements from day one.
2. Targeting Intelligence: Empowering dynamic targeting at speed. Refresh segmentation strategies in days, not months, and stay ahead with AI-powered adaptability.
3. Performance Intelligence: Providing real-time territory insights for personalized coaching. This module equips every rep with data-driven performance strategies for measurable success.

Last year, we unveiled the foundation of our platform, our AI engines, showcasing ODAIA's commitment to cutting-edge technology. These engines form the backbone of our predictive analytics, delivering 90%+ TRx prediction accuracy. 

We announced our AI Voice Assistant, available for early adopters in Q2 2025. This revolutionizes how sales reps interact with their data and insights. Offering reps with a hands-free solution allows them to access critical insights on-the-go, further streamlining their workflow.

ODAIA expanded its integration capabilities, adding Snowflake and Salesforce to our growing list of supported platforms. These integrations enable bidirectional data flow and enhanced analytics capabilities for our customers.

Product Evolution – Enhancing our Core Offerings 

At ODAIA, our commitment to innovation goes beyond introducing new features—it's about continuously refining our platform to solve real-world challenges for pharma commercial teams. In 2024, our product and engineering teams focused on critical improvements that streamline sales rep workflows, enhance HCP engagement, and ultimately help pharma companies deliver life-changing treatments more efficiently. These enhancements reflect our dedication to creating intelligent, user-centric solutions, transforming how commercial teams operate.

• Dynamic Segmentation: Improved algorithms for precision HCP targeting.
• Account Selling: New features supporting both retail and direct selling models.
• Multi-Product Selling: Rolled out multi-product or multi-indication targeting for reps with larger portfolios.
• Role-Based Access: 
• Behavioral Segmentation: Developed an algorithm to identify New Writers before they write their first script. 

Advanced predictive metrics and insights were introduced this year, enabling more targeted and effective HCP engagement strategies.

• Enhanced loading & query times across the platform.
• Improved graphs, reporting, and data visualization in ODAIA Field and Field Coach.
• Upgraded territory overview dashboards for better strategic planning.

Industry Connections – Bridging Innovation Across Pharma Ecosystems 

In 2024, ODAIA recognized that true innovation happens at the intersection of diverse perspectives. By participating in key events, we not only showcased our solutions but also listened, learned, and collaborated with stakeholders who are transforming the pharmaceutical landscape. Each interaction is an opportunity to bridge gaps, share knowledge, and demonstrate how AI can drive meaningful change across different organizational functions.

We were grateful to meet so many innovators this year at: 

• Veeva Commercial Summit (North America & Europe) 
• Snowflake Data Cloud Summit (London & San Francisco) 
• Reimagine Pharma Marketing Summit 
• Pangora Pharma CX Summit 
• Digital Pharma East 
• Future Pharma Marketing Summit 

Insights for Innovation – Empowering Pharma Leaders 

Our commitment to thought leadership goes beyond product development—we strive to be a valuable resource that challenges the status quo, sparks innovation, and guides our partners through their AI journey. By sharing our experience, best practices, and industry trends, we aim to illuminate the path forward, helping pharma companies modernize their operations and unlock new possibilities in HCP engagement and patient care.

Content Highlights: 

• Guide to AI in Pharma: This comprehensive three-part blog series explores the potential of AI in pharma, ensuring successful AI adoption, and practical implementation steps. It compares deployment strategies, helping companies decide whether to build AI internally, buy solutions, or partner with providers.

• 2024 Everest Peak Matrix Assessment Report: Available for download, this report highlights ODAIA as the only vendor with dual recognition as both a star performer and major contender. Our inclusion as a young startup among legacy solutions demonstrates our innovative AI approach and the industry's growing need for agile, rapid time-to-value solutions.

• Panel Discussion: The Real Impact of AI in Pharma: This insightful session features thought leaders from GSK, Novo Nordisk, and Peak Pharma discussing the tangible value and impact of AI in their commercial operations.

• Innovation Theatre Session: Veeva EU Summit: Led by Philip Poulidis and Parth Patel, this popular session showcased AI-driven call planning, pre-call insights, route optimization, and the new Voice Assistant, demonstrating ODAIA's cutting-edge solutions in action.

Looking Ahead – 2025 and Beyond 

As we move into 2025, ODAIA remains committed to driving innovation for pharma commercial teams. By continuously enhancing our AI capabilities, expanding integrations, and developing new features that deliver tangible value to our customers. Our focus remains on empowering pharma teams to engage HCPs more effectively while improving patient outcomes through data-driven decision-making.

2024 has set a strong foundation for ODAIA's continued growth. We’re excited to build on this momentum alongside our partners and customers as we shape the future of AI in pharma.